Danish, and Nordic, giant Novo Nordisk has presented its results for the fourth quarter of 2018 – a little lower than expected and the company intends to initiate a new
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
NLS News
Klaria and Purdue Pharma have announced they have entered into an exclusive development agreement for KL-01401 (Epinephrine Oromucosal Film). KL-01401 is a developmental stage formulation of epinephrine for emergency treatment
Before Christmas the company announces that the transformation to focus the company’s internal resources on its clinical development projects has now been completed. Redundancies, mainly within research and administration, are
The Danish biotech company has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to combat antimicrobial resistance (AMR). An additional
The patent protects Targovax’ mutant-RAS specific neoantigen peptides, mutant RAS specific T cells and vaccines TG01 and TG02, for the treatment of cancer in combination with chemotherapies. “We are delighted
AstraZeneca’s partner Ironwood Pharmaceuticals has received marketing authorization from the National Medical Products Administration (NMPA) for Linzess (linaclotide) in China for the treatment of adult patients with irritable bowel syndrome with
The Food and Drug Administration (FDA) and the Central Ethics Committee in the United States have accepted Xbranes IND application for initiation of the Xplore trial, a phase III trial
The U.S. Biomedical Advanced Research and Development Authority (BARDA) have exercised another option under the ongoing contract for freeze-dried MVA-BN smallpox vaccine. The option, valued at USD 44 million, will
Using DNA origami – DNA-based design of precise nanostructures – scientists at Karolinska Institutet in Sweden and at University of Oslo, Norway, have been able to demonstrate the most accurate
The company has announced organizational changes, including the development of R&D and commercial units in its biopharmaceuticals area and in oncology. In addition, three senior executives leaves the company and
Bristol-Myers Squibb (BMS) and Celgene have announced that they have entered into a definitive merger agreement under which BMS will acquire Celgene in a cash and stock transaction with an
The company is launching Rexulti (brexiprazole) for the treatment of adult patients with schizophrenia in Switzerland from 1 January 2019. The launch is the first in a sequence that will
Sprung from the University of Linköping’s world-renowned Center for Medical Image Science and Visualization and the departments of Biomedical Engineering and Medicine and Health, AMRA has become an international digital
Sponsored content
Vitality: Understanding the lifespan of vaporized H2O2 sensors
A unique feature of the HPP270 series probes is the ability to evaluate the sensors’ performance through its “Sensor Vitality” value. This value is like a health check for the sensor.
JOB ALERTS
Read the latest issue of our magazine!
No 01 2024 // Many scientists state that we are entering the golden age of CNS disease treatment. Learn more about some of the most recent progress being made within the field, including Nordic advances. This issue’s profile is professor Mia Phillipson, co-founder of Ilya Pharma, co-director at SciLifeLab, a member of the Royal Swedish Academy of Sciences, and a scientist pioneering immunotherapies. We have a special report on the life science financial landscape, including VC predictions for 2024, an interview with Thomas Eldered, Flerie Invest, and a global outlook. This issue also includes a special focus on the skills shortages within cell and gene therapy manufacturing, startup advice and what it is like to work as a Bioprocess Engineer.
The latest research news from the Nordic region
Nordic Life Science
The latest clinical trials
Sign up to our newsletter